CURRICULUM VITAE. Key Qualifications: Internal Medicine Specialist and Medical oncologist. Name of Hospital: Firat Universitesi Hastanesi
|
|
- Magnus Fleming
- 8 years ago
- Views:
Transcription
1 CURRICULUM VITAE Personal Details Surname: Elkiran First Name: Emin Tamer Akademic title/ position: Associate professor of Medicine Key Qualifications: Internal Medicine Specialist and Medical oncologist Research Interest: Solid and hematologic malignancies International Experience/Collaborations: Contact Details: Work Address: Name of Hospital: Firat Universitesi Hastanesi Street: Universite Mahallesi Town: Elazig Country:Turkey Post Code: Phone/Fax: /Ext: Date of Birth: Place and Country of Birth: Hekimhan-Malatya-Turkey Country of Citizenship: The Republic of Turkey Country of Training: Turkey First Language: Turkish Languages: English Akademic Details
2 Faculty/University ( name and address) Date of Graduation:1993 Ankara University Faculty of Medicine- Ankara-Turkey Postgraduate Training: ( Name and address of Center and Supervisor [s] in charge of Training) 1-Cukurova University Faculty of Medicine, Department of Internal Medicine-Adana-Turkey 2-Hacettepe University Faculty of Medicine, Department of Medical Oncology-Ankara- Turkey SUPERVISOR IN CHARGE OF TRAINING: From To Title of thesis: 1-Spontaneous ascite infection in cirrhotic patient, (Thesis of internal medicine) 2-Retrospective analysis of osteosarcoma patients, (Thesis of medical oncology) Accreditation: (Name, number and date of certificate issued by Universty, Medical Association or Government Body) Academic Experience: Cukurova University Faculty of Medicine, Department of Internal Medicine-Adana-Turkey 2-Hacettepe University Faculty of Medicine, Department of Medical Oncology Cukurova University Faculty of Medicine, Department of Internal Medicine Dec 1993-June 1998 Adana Karaisali Hospital June 1998-April 1999 Firat University Faculty of Medicine, Department of Internal Medicine April 1999-June 1999 Ankara University Faculty of Medicine, Department of Hematology June 1999-Augus 1999 Firat University Faculty of Medicine, Department of Internal Medicine Sep 1999-Oct 2001 Hacettepe University Faculty of Medicine, Department of Medical Oncology Oct Oct 2004 Firat University Faculty of Medicine, Department of Internal Medicine Since Oct 2004 Memberships: 1- Society of Medical Oncology 2-Anatolian Society of Medical Oncology
3 3-Turkish Society of Hematology 4-Turkish Oncology Group International Publications 1. Elkiran, E. T., K. Altundag, S. Aksoy, I. K. Onal and G. Tekuzman, Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma, Am. J. Hematol, 75, 265 (2004). 2. Altundag, K., E. T. Elkiran and O. Altundag, Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma, Cancer, 100, (2004). 3. Altundag, K., O. Altundag, E. T. Elkiran, M. Cengiz and Y. Ozisik, Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells, Med. Hypotheses, 63, (2004). 4. Babaoglu, M. O., O. Karadag, Y. Saikawa, K. Altundag, T. Elkiran, U. Yasar and A. Bozkurt, Hepatotoxicity due to a possible ınteraction between cytosine arabinoside and dipyridamole: a case report, Eur. J. Clin. Pharmacol, 60, (2004). 5. Ozcakar, L., O. Karadag, M. Isik, E. T. Elkiran, O, Dikbas and K, Altundag, Progressive ascending paraparesia in an acute lymphoblastic leukemia patient: masked but not fallacious, J. Exp. Clin. Cancer Res, 23, (2004). 6. Karadag, O., M. O. Babaoglu, K. Altundag, T. Elkiran, U. Yasar and A. Bozkurt, 5- Fluorouracil-induced coronary spasm: may inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?, Oncology, 66, (2004). 7. Elkiran, E. T., K. Altundag, Y. Beyazit, N. Guler and A. Kars, Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure, Ann. Pharmacother, 38, 2171 (2004). 8. Karadag, O., K. Altundag, E. T. Elkiran, O. Dikbas, G. Gedikoglu and A. Kars, Anterior abdominal wall synovial sarcoma: a rare presentation, Am. J. Clin. Oncol, 28, (2005). 9. Kurt, M., I. K. Onal, T. Elkiran, B. Altun, K. Altundag and I. Gullu, Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma, Med. Oncol, 22, (2005). 10.Kurt, M. A. Shorbagi, K. Altundag, T. Elkiran, I. Gullu and E. Kansu, Possible association between budd-chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia, Am. J. Hematol, 80, (2005).
4 11. Elkiran, E. T., B. Aygen, A. Karaoglu and K. Altundag, Metastatic osteosarcoma to the brain in adult patient, J. Neurooncol, 76, 213 (2006). 12. Elkiran, T., H. Harputluoglu, U. Yasar, M. O. Babaoglu, A.K. Dincel, K. Altundag, Y. Ozisik, N. Guler and A. Bozkurt, Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients, Methods Find. Exp. Clin. Pharmacol., 29, (2007). 13. Elkiran, E. T., H. Abali, S. Aksoy, K. Altundag, M. Erman, A. Kars, A. Turker, G. Tekuzman and Y. Ozisik, Thymic epithelial neoplasia: a study {Okumura, Ohta, et al /id}of 58 cases, Med. Onco., 24, (2007). 14. Elkiran, E. T., Mar, N., Aygen, B., Gursu, F., Karaoglu, A. and Koca, S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population BMC Cancer, 7, 48, (2007). 15. Aydin, S., Geckil, H., Karaoglu, A., and Elkiran, E. T. Ghrelin: a novel peptide with therapeutic effect in certain cancers? Med Hypotheses, 69, , (2007). 16. Ozcakar, L., Elkiran, T., Altundag, K., and Tayfur, O. A fortuitous episode of brachial plexopathy in a patient with metastatic breast cancer Surg Neurol, 69, (2008 ). Presentations at International Scientific Meetings 1. Çeliker, H., B. Elkıran, Đ. H. Behçecioğlu, A. Demir and E. T. Elkıran, Yeni tanı almış kronik böbrek yetmezliği hastalarında endoskopik bulgular, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 217, Đzmir, Çeliker, H., B. Elkıran, E. T. Elkıran, Đ. H. Behçecioğlu and A. Demir, Kronik böbrek yetmezliği hastalarında hepatobiliyer değişiklikler, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 218, Đzmir, Çeliker, H., B. Elkıran, N. Đlhan, A. Var and E. T. Elkıran, Hemodializ ve periton diyalizinin oksidatif stres parametrelerinin üzerine etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Đzmir, Đlhan, N., A. Var, H. Çeliker, B. Elkıran and E. T. Elkıran, Hemodializ hastalarında oksidan ve antioksidan parametreler üzerine yaş ve cinsiyetin etkisi, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 225, Đzmir, 1999.
5 5. Elkıran, B., H. Çeliker, E. T. Elkıran, A. Var and N. Đlhan, Hemodializ hastalarında oksidatif stres üzerine trimetazine in etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 226, Đzmir, Çeliker, H., B. Elkıran, E. T. Elkıran and A. Đ. Günal, Üremik hastalarda depresyon, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 272, Đzmir, Var, A., N. Đlhan, H. Çeliker, B. Elkıran and E. T. Elkıran, Değişik membran tiplerin oksidan-antioksidan sistem parametreleri üzerine etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 276, Đzmir, Abali, H., A. Türker, B. Öksüzoglu, T. Elkiran, M. Erman, Y. Ozişik and A. Kars, Primitive neuroectodermal tumor and Ewings sarcoma: Experience in adults at a tertiary care hospital, 27 th ESMO Congress, Nice, France, Annals of Oncology, Vol. 13, , Elkiran, T., B. Oyan, Y. Koç, A. Kars, A. Türker, F. Tekin, Y. Cetinkaya, O. Uzun, M. Akova, S. Unal, G. Tekuzman and E. Kansu, Infection complications during nonmyeloablative allogenic transplantation, XVII th Meeting Of The International Society Of Hematology (European & African Divison), Graz, Austria, 60, Aksoy, S., H. Abali, S. Kiliçkap, O. Yavas, B. Oyan, E. T. Elkiran, T. Aras, O. Ugurlu, N. Güler and G. Tekuzman, Outcome of well differentiated thyroid cancer: Single institution results 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), J. Clin. Oncology, Vol. 22, 5615, Aygen, B., E. T. Elkıran, A. Karaoğlu and N. Akpolat, An unusual tumor of the renal pelvis: primary mucinous adenocarcinoma. A case report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 282, Elkiran, T., N. Akpolat and B. Aygen, Extraskeletal osteosarcoma of the gluteal region: Case Report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul- Turkey, 265, Elkiran, T., B. Aygen and H. Yekeler, A case of bone marrow necrosis as the etiology of severe pancytopenia XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 224, Elkiran, E. T., S. Çelebi, B. Aygen, A. Karaoğlu and I. Özercan, Primary malignant melanoma of esophagogastric junction: A case report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 203, Elkiran, E. T., B. Aygen and Özercan I, A rare case of primary squamous cell carcınoma of the breast in a young woman, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 142, 2005.
6 16. Elkıran, E. T. and B. Aygen, Simultaneous occurrence of Hodgkin Lymphoma and tuberculosis: A case report, XXX th World Congress of the International Society of Hematology Đstanbul, Turkish Journal of Haematology (Supplement), Vol. 22, 178, Elkıran, T. and B. Aygen, Dental Filling: Cause of eosinophilia, XXX th World Congress of the International Society of Hematology, Đstanbul, Turkish Journal of Haematology (Supplement), Vol. 22, 204, Elkiran, E. T., K. Altundag, M. O. Babaoglu, U. Yasar, Y. Ozisik, N. Guler, A. Kara Dincel, and A. Bozkurt, Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide / adriamycin administration in operable breast cancer patients 2005 ASCO Annual Meeting Proceedings, J. Clin. Oncology, Vol. 23, No. 16S, Elkiran, E. T., N. Mar, B. Aygen, Gursu F, Koca S and A. Karaoglu, Serum paraoxonase activity changes in patients with lung cancer, 31 st ESMO Congress, Đstanbul, Turkey, Annals of Oncology, Vol. 17, ix253, Elkiran, E. T., A, Türker, A. Kars, H. Harputluoglu, M. Erman, G. Gedikoglu and G. Tekuzman, Retrospektive evaluation of osteosarcomas of the extremity in adults, 31 st ESMO Congress, Đstanbul, Turkey, Annals of Oncology, Vol. 17, ix166, 2006.
CURRICULUM VITAE. Research Interest: Bresat Cancer, Gyneocologic Cancer, Colorectal Cancer, Lung Cancer.
CURRICULUM VITAE Personal Details Surname: KARAOGLU First Name: Aziz Akademic title/ position: Asscociate Proffessor Key Qualifications: -Internal Medicine, -Medical Oncology Research Interest: Bresat
More information4-Deveci F, Akbulut HH, Çelik I, Muz MH Ilhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients, Mediators Inflamm., 2006;(2);89070.
CURRICULUM VITAE Personal Details Surname: Muz Frst Name: Mehmet Hamdi Academic title/position: Prof. Dr.- President of Chest Disease Departmant Key Qualifcations: Research Interest: Lung Cancers Đnternational
More informationCURRICULUM VITAE. Personal Details. Surname: Akbulut. Frst Name: Hatice Handan. Academic title/position: Prof, Departmant of Immunology
CURRICULUM VITAE Personal Details Surname: Akbulut Frst Name: Hatice Handan Academic title/position: Prof, Departmant of Immunology Key Qualifcations: Research Interest: IFA, Flow cytometry, Evaluation
More informationSUPERVĐSOR ĐN CHARGE OF TRAINING: Şef Dr Kunter Perim
CURRICULUM VITAE Personal Details Surname: Deveci First Name: Figen Academic title/position: Prof, Departmant of Chest Disease Key Qualifcations: Research Interest: Asthma Bronchiale Đnternational Experience/Collaborations:
More informationNew Hampshire Childhood Cancer
Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children
More informationImmunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
More informationWhat is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationMOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
More informationMedical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationCord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD
Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationFINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 1 st TURKISH-HELLENIC POSTGRADUATE CONTINUOUS MEDICAL EDUCATION MEETING MAY 6-9, 2011, IZMIR, TURKEY DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E.
More informationCURRICULUM VITAE. Personal Details. Surname: Isik. First Name: Ahmet. Akademic title/ position: Professor of Medicine
CURRICULUM VITAE Personal Details Surname: Isik First Name: Ahmet Akademic title/ position: Professor of Medicine Key Qualifications: Internal Medicine Specialist and Romatologist Research Interest: International
More informationSpecific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
More informationMEDICAL POLICY POLICY TITLE
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): Effective Date: April 15, 2008 July 1, 2009- RETIRED I. DESCRIPTION/BACKGROUND High dose chemotherapy (HDC) involves the administration
More informationOncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING
Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING Client opportunities CONTENTS About us...02 Readership...04 Driving qualified leads...05 Our Journals...08 Editorial Calendar...10 Rate
More informationRole of clinical trials in professional development
Role of clinical trials in professional development Peeter Padrik Tartu University Hospital University of Tartu Estonian Society for Medical Oncology How we do treatment decisions? Personal experience?
More informationXIV ANNUAL MEETING OF NURSING
Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I
More information4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma
Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer
More informationCURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system
CURRICULUM VITAE Personal Details Surname: BAHCECIOGLU First Name: Ibrahim Halil Akademic title/ position: Prof. Dr. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system Research Interest:
More informationSeattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.
Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case
More informationCURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery
CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723
More informationSecond Cancers in Adults
Second Cancers in Adults This document focuses on second cancers in adults. For information about second cancers after treatment of childhood cancers, see our document Children Diagnosed With Cancer: Late
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationA Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology
A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology Feb 2010 Royal College of Paediatrics and Child Health www.rcpch.ac.uk Royal College of Paediatrics and Child
More informationCAR T cell therapy for lymphomas
CAR T cell therapy for lymphomas Sattva S. Neelapu, MD Associate Professor and Deputy Chair ad interim Department of Lymphoma and Myeloma UT MD Anderson Cancer Center, Houston, TX CAR T cell therapy What
More informationSite Specific Oncology Clinical Enrichment Brochure for non-ui Hospitals and Clinics staff
University of Iowa Hospitals and Clinics Services and Patient Care Nursing Clinical Education Center 4 West, General Hospital 319-356-4304 Tel Nursing CEU Credit: CEUs will be granted by UIHC (IBN Approved
More informationEDUCATIONAL STATUS & DEGREES
CURRICULUM VITAE Fatma ÇELİK, MSc Adress: Hacettepe Universitesi, Saglik Bilimleri Fakultesi, Beslenme ve Diyetetik Bolumu, D-blok 06100 Sihhiye/Ankara Telephone : +90 (0312) 3051094-152 E-mail: fatma.celik@hacettepe.edu.tr
More informationSECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic
More informationInteresting Case Series. Periorbital Richter Syndrome
Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,
More informationLung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
More informationMetastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011
Metastatic Breast Cancer 201 Carolyn B. Hendricks, MD October 29, 2011 Overview Is rebiopsy necessary at the time of recurrence or progression of disease? How dose a very aggressive treatment upfront compare
More informationCancer in Children. What is cancer?
What is cancer? Cancer in Children The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly fashion. During the early years of a person
More informationCancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
More informationBONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT
SATURDAY SEPTEMBER 27, 2014 THE HOTEL HERSHEY 100 Hotel Road, Hershey, PA 17033 BONE MARROW FAILURE DISEASE SYMPOSIUM AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT A CONTINUING EDUCATION SERVICE OF
More informationMayo Clinic College of Medicine Pharmacy Services. Rotation Summary
Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron
More informationResumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
More informationRole of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases
Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases R. Shraddha, P.N. Pandit Radium Institute, Patna Medical College and Hospital, Patna, India Abstract NHL is a highly
More informationCURRICULUM VITAE. Personal Details. Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology
CURRICULUM VITAE Personal Details Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology Research Interest: Infectious Diseases International Experience/Collaborations:
More informationPRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
More informationSmall Cell Lung Cancer
Small Cell Lung Cancer Lung Practice Guideline Dr. Brian Dingle MSc, MD, FRCPC Approval Date: April 2007 Revised: November 2008 This guideline is a statement of consensus of the Thoracic Disease Site Team
More informationPOLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
More informationNational Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div.
Dated 21 st November 2014 NPPA Invites Comments of Pharmaceutical Industry & Trade, Consumer Organisations, Public Health Experts and other Stakeholders on the Recommendations of Tata Memorial Centre under
More information1998-2004 Medical Faculty Hacettepe University Faculty of Medicine (English Section) Ankara
PERSONAL INFORMATION: Name: Surname: Umut Sinan ERSOY Birth Date: June 16 th, 1981 Birth Place: Natioanality: Marital Status: Title: Adana, Turkey Republic of Turkey Single Medical Doctor Work Address:
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
More informationCURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology
CURRICULUM VITAE Personal Details Surname: Akbulut First Name: Mehmet Academic title/position: Professor Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology Research
More informationCo-pay assistance organizations offering assistance
Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationMALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
More informationBone Marrow/Stem Cell Transplant
Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based
More informationCourse Curriculum for Master Degree in Clinical Pharmacy
Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon
More informationFor personal use only
The Company Announcements Platform ASX Limited By E-lodgement PTX Shareholder Newsletter 9 November 2015, Melbourne, Australia: Prescient Therapeutics Limited (ASX: PTX), a clinical stage oncology company,
More informationCANCER TREATMENT: Chemotherapy
CANCER TREATMENT: Chemotherapy Chemotherapy, often called chemo, is the use of drugs to treat a disease. The term chemotherapy is now most often used to describe a type of cancer treatment. Dr. Khuri:
More informationinformation for payers and referrers
a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m information for payers and referrers Spring 2014 For more information, visit www.dfbwcc.org/bmt. o u r expertise Since its founding in
More informationUmbilical Cord Blood Stem Cells Current Status & Future Potential
Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu
More informationCarcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
More informationIntroduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each
Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including
More informationCURRICULUM VITAE. International Experience/Collaborations: Wadsworth Center, State University, Albany, New York, USA
CURRICULUM VITAE Personal Details Surname: Bulut First Name: Yasemin Academic title/position: Associate Professor Key Qualifications: Laboratory diagnosis of viral diseases Epidemiology of viral infection
More informationE UROPEAN CURRICULUM VITAE FORMAT
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto
More informationFalse positive PET in lymphoma
False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)
More informationPathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France
Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France Bone metastases 70 % of prostate and breast cancers 30 % of lung, bladder and thyroid
More informationFeline Lymphoma Chemotherapy and Chemotherapy Protocols
Feline Lymphoma Chemotherapy and Chemotherapy Protocols If you have reached this page, your cat probably has a definite diagnosis of feline lymphoma from your veterinarian. The information below is not
More informationWhite Paper. Understanding the Scope and Challenges of Childhood Cancer. Introduction
White Paper Understanding the Scope and Challenges of Childhood Cancer Introduction Imagine a world without childhood cancer. No painful chemotherapy treatments. No emotional stress on children and their
More informationGRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
More informationmicrorna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS
microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS 1st International Congress on Controversies in Personalized Oncology (CONPO) BARCELONA, SPAIN MARCH
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationStem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationThe Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma
The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma 11 th Annual National Leadership Summit on Health Disparities Innovation Towards Reducing Disparities Congressional Black
More informationEstimated New Cases of Leukemia, Lymphoma, Myeloma 2014
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
More informationHepatocellular Carcinoma (HCC)
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
More informationVeterinary Oncology: The Lumps We Hate To Treat
Veterinary Oncology: The Lumps We Hate To Treat Michelle Turek, DVM, DACVIM (Oncology), DACVR (Radiation Oncology) College of Veterinary Medicine University of Georgia Athens, GA Veterinary Oncology Veterinary
More informationMETROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188
METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188 POLICYHOLDER: NORFOLK PUBLIC SCHOOLS Group Policy Form No: GPNP04-CI (Referred to herein as the Group Policy ) Certificate
More informationThis module consists of four units which will provide the user a basic knowledge of cancer as a disease.
Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define
More informationChildhood Cancer in the Primary Care Setting
Childhood Cancer in the Primary Care Setting Mohamed Radhi, M.D. Associate Professor, UMKC Pediatric Hematology/Oncology/BMT Children s Mercy Hospital I will discuss: Overview of childhood cancer Presentation
More informationOPTIONAL Group Critical Illness For peace of mind
OPTIONAL Group Critical Illness For peace of mind A Critical Illness Program for the members of: The Ontario Dental Hygienists Association Administered by: LMS PROLINK Ltd. 1 ACE INA Life Insurance Guaranteed
More informationAsst. Prof. Kerem OK Işık University Facult of Arts and Sciences Department of Information Technologies kerem.ok@isikun.edu.tr
Asst. Prof. Kerem OK Işık University Facult of Arts and Sciences Department of Information Technologies kerem.ok@isikun.edu.tr 1. Name Surname : Kerem OK 2. Birth Date : 02.11.1984 3. Academic Title :
More informationNews Release. Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Your Contacts News Release Merck KGaA, Darmstadt, Germany Media: Markus Talanow +49 6151 72 7144 Investor Relations +49 6151 72 3321 Pfizer Inc., New York, USA Media: Sally Beatty +1 212 733 6566 Investor
More informationCytopathology Case Presentation #8
Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents
More informationYour Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer
Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis
More informationCritical Illness Supplemental Insurance
You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Supplemental Insurance It s cash when you need it. You choose how to spend it. So you can focus
More informationJune 27, 2015 Radisson Blu Hotel Sisli - Istanbul
5 June 27, 2015 Radisson Blu Hotel Sisli - Istanbul INVITATION On behalf of the Turkish Medical Oncology Society Executive Committee, it th is my pleasure to invite you to join the 6 ASCO-licensed "Best
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationAriela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae
Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it
More informationLong Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia
Long Term Low Dose Chemotherapy in the Treatment of Acute Myeloid Leukemia Murat TOMBULO LU*, Seçkin ÇA IRGAN* * Department of Hematology, Faculty of Medicine, Ege University, zmir, TURKEY ABSTRACT In
More informationAnti-PD1 Agents: Immunotherapy agents in the treatment of metastatic melanoma. Claire Vines, 2016 Pharm.D. Candidate
+ Anti-PD1 Agents: Immunotherapy agents in the treatment of metastatic melanoma Claire Vines, 2016 Pharm.D. Candidate + Disclosure I have no conflicts of interest to disclose. + Objectives Summarize NCCN
More informationHow To Raise Money For Rare Cancer Research
Our 2014 Impact Funding Allocations Cycle for Survival funds promise: Our donations launch and accelerate research studies and clinical trials that drive discovery. By helping fill the funding gap in rare
More informationDiagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationMedical Surgical Nursing (Elsevier)
1 of 6 I. The Musculoskeletal System Medical Surgical Nursing (Elsevier) 1. Med/Surg: Musculoskeletal System: The Comprehensive Health History 2. Med/Surg: Musculoskeletal System: A Nursing Approach to
More informationtreatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can
Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods
More informationNational Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute
More informationProgressive Care Insurance for life A NEW TYPE OF INSURANCE
Progressive Care Insurance for life A NEW TYPE OF INSURANCE New Progressive Care from Sovereign Progressive Care is a type of insurance that is new to New Zealand. It s not a traditional all-or-nothing
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PS Inj - Alimta Therapeutic Class: Antineoplastic Agents Therapeutic Sub-Class: Antifolates Client: PS Inj Approval Date: 8/2/2004 Revision Date: 12/5/2006 I. BENEFIT
More informationHow To Treat A Cancer With Natural Remedies
Mesothelioma is a devastating form of cancer that is relatively rare when compared to the incidence rates of other cancers. The word mesothelioma is derived from the English word mesothelium, which is
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationSMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
More information